TrademarkDir
DASH DOSE
LIVE

Serial Number

88982456

Owner

NATCO PHARMA USA LLC

Attorney

Michael A. Marrero

First Use Date

Mar 23, 2021

Filing Date

Jan 24, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DASH DOSE Trademark

Serial Number: 88982456 • Registration: 6472306

DASH DOSE is a trademark filed by NATCO PHARMA USA LLC on January 24, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NATCO PHARMA USA LLC (11 trademarks)

2 PARK WAY
UPPER SADDLE RIVER, NJ 07458

Entity Type: 16

DASH PHARMACEUTICALS LLC (8 trademarks)

2 PARK WAY
UPPER SADDLE RIVER, NJ 07458

Entity Type: 16

Fidelity Pharmaceuticals LLC (10 trademarks)

2 Park Way
Upper Saddle River, NJ 07458

Entity Type: 16

Trademark Details

Filing Date

January 24, 2020

Registration Date

August 31, 2021

First Use Anywhere

March 23, 2021

First Use in Commerce

March 23, 2021

Published for Opposition

June 2, 2020

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 19, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 19, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 19, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 19, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 19, 2024 COAR
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Jan 9, 2024 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Dec 4, 2023 COC.
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Dec 2, 2023 EROP
POST REGISTRATION ACTION MAILED - SEC. 7
Nov 28, 2023 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 21, 2023 APRE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 17, 2023 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 19, 2023 ASGN
TEAS SECTION 7 REQUEST RECEIVED
Apr 5, 2023 ES7R
REGISTERED-PRINCIPAL REGISTER
Aug 31, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 30, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 29, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 27, 2021 SUPC
DIVISIONAL PROCESSING COMPLETE
Jul 27, 2021 DPCC
USE AMENDMENT FILED
Jul 12, 2021 IUAF
DIVISIONAL REQUEST RECEIVED
Jul 12, 2021 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jul 12, 2021 ERTD
TEAS STATEMENT OF USE RECEIVED
Jul 12, 2021 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jul 7, 2021 EX2G
SOU EXTENSION 2 FILED
Jul 7, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 7, 2021 EEXT
CORRECTED NOA E-MAILED
Feb 3, 2021 NOAC
DIVISIONAL PROCESSING COMPLETE
Jan 29, 2021 DPCC
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 23, 2021 EXRA
DIVISIONAL REQUEST RECEIVED
Jan 22, 2021 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jan 22, 2021 ERTD
SOU EXTENSION 1 GRANTED
Jan 21, 2021 EX1G
SOU EXTENSION 1 FILED
Jan 21, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 21, 2021 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 23, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 23, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 23, 2020 COAR
CORRECTED NOA E-MAILED
Nov 10, 2020 NOAC
DIVISIONAL PROCESSING COMPLETE
Nov 9, 2020 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 15, 2020 AITU
DIVISIONAL REQUEST RECEIVED
Sep 4, 2020 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Sep 4, 2020 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 28, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 2, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2020 NONP
ASSIGNED TO LIE
Apr 23, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 15, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 15, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 15, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 15, 2020 CNEA
ASSIGNED TO EXAMINER
Apr 14, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2020 NWOS
NEW APPLICATION ENTERED
Jan 28, 2020 NWAP

Related Trademarks

More from this Owner

NATCO PHARMA USA

NATCO PHARMA USA

NATCO PHARMA USA

NATCO PHARMA USA

NATCO PHARMA USA

NATCO PHARMA USA

NATCO

NATCO

NATCO

NATCO

NATCO

NATCO